• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.66% Nasdaq Down1.05%

    AbbVie Inc. (ABBV)

    -NYSE
    59.77 Down 1.81(2.94%) Sep 4, 4:00PM EDT
    |After Hours : 59.94 Up 0.17 (0.28%) Sep 4, 7:51PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    AbbVie Inc.
    1 North Waukegan Road
    North Chicago, IL 60064
    United States - Map
    Phone: 847-932-7900
    Website: http://www.abbvie.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:28,000

    Business Summary 

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-oral, short-course, interferon-free therapy, with or without ribavirin, for adult patients with genotype 1 chronic hepatitis, including those with compensated cirrhosis; Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in people with HIV-1; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1 infection; and Synagis to prevent respiratory syncytial virus infection in high risk infants. It also provides AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and the treatment of endometriosis and central precocious puberty, as well as for the preoperative treatment of patients with anemia. In addition, the company offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, Niaspan, Simcor, and Advicor to treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has strategic collaboration with Calico Life Sciences LLC, Infinity Pharmaceuticals, Inc., Ablynx NV, Galapagos NV, Alvine Pharmaceuticals, Inc., and Action Pharma A/S. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on AbbVie Inc.

    Corporate Governance 
    AbbVie Inc.’s ISS Governance QuickScore as of Sep 1, 2015 is 7. The pillar scores are Audit: 2; Board: 6; Shareholder Rights: 9; Compensation: 2.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Richard A. Gonzalez , 61
    Chairman, Chief Exec. Officer and Chairman of Exec. Committee
    5.82M0.00
    Mr. William J. Chase , 47
    Chief Financial Officer and Exec. VP
    2.54M373.00K
    Mr. Michael Severino M.D., 49
    Chief Scientific Officer and Exec. VP of R&D
    2.91M0.00
    Ms. Laura J. Schumacher , 52
    Exec. VP of Bus. Devel. & External Affairs, Gen. Counsel and Corp. Sec.
    2.85M67.00K
    Mr. Carlos Alban , 52
    Exec. VP of Commercial Operations
    3.73M0.00
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders